Drug and pharmaceutical recalls
754 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health testosterone pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIStop using Asteria Health estradiol pellets
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugF.H. INVESTMENTS, Inc. (dba Asteria Health)Class IIESTRADIOL, 6 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3006-32.
Presence of Foreign substance - potential presence of metal particulate matter
- 2026-02-18FDA-DrugUnichem Pharmaceuticals USA Inc.Class IIIStop using Unichem Doxazosin 4 mg tablets
Tablets/Capsules Imprinted with Wrong ID
- 2026-02-18FDA-DrugPro Numb Tattoo Numbing Spray LLCClass IIStop using Pro Numb Tattoo Numbing Spray
cGMP deviations
- 2026-02-18FDA-DrugPro Numb Tattoo Numbing Spray LLCClass IIStop using Pro Numb Tattoo Numbing Spray
cGMP deviations
- 2026-02-11FDA-DrugSUN PHARMACEUTICAL INDUSTRIES INCClass IIStop using Sun Pharmaceutical Diclofenac Sodium Gel
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
- 2026-02-11FDA-DrugHANDELNINE GLOBAL LLCClass IStop using Rheumacare capsules
CGMP Deviations: product found to contain lead.
- 2026-02-11FDA-DrugGranules Pharmaceuticals Inc.Class IIStop using Granules trazodone 50 mg
Presence of Foreign Tablets/Capsules
- 2026-02-11FDA-DrugGreen Lumber Holdings, LLCClass IStop using Green Lumber Natural Fuel For Men
Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil
- 2026-02-11FDA-DrugUnichem Pharmaceuticals USA Inc.Class IIStop using Unichem bisoprolol/hydrochlorothiazide tablets
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
- 2026-02-04FDA-DrugNOVADOZ PHARMACEUTICALS LLCClass IIIStop using recalled Novadoz glycopyrrolate solution
Failed Impurities/Degradation Specifications
- 2026-02-04FDA-DrugGreenstone LlcClass IIStop using Greenstone methylprednisolone Dosepak
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
- 2026-02-04FDA-DrugSato Pharmaceutical Co., LtdClass IIStop using Sato INON ACE antacid tablets
Failed Disintegration Specifications: above the time expected.
- 2026-02-04FDA-DrugHaleon US Holdings LLCClass IIICheck your Parodontax mouthwash lot number
Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.
- 2026-02-04FDA-DrugBaxter Healthcare CorporationClass IIStop using Baxter Sterile Water for Irrigation
Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution
- 2026-01-28FDA-DrugZydus Pharmaceuticals (USA) IncClass IIStop using Zydus Icosapent Ethyl capsules
Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
- 2026-01-28FDA-DrugSpecialty Process Labs LLCClass IIStop using Specialty Process Labs Thyroid USP
Subpotent Drug
- 2026-01-28FDA-DrugGraviti Pharmaceuticals Private LimitedClass IIStop using Rising Pharmaceuticals Furosemide tablets
Presence of Foreign Substance
- 2026-01-28FDA-DrugCipla USA, Inc.Class IIIStop using Cipla Diclofenac Sodium Topical Gel
Failed PH Specifications
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief